ASP Isotopes (ASPI) Competitors

Chemours (NYSE:CC) and ASP Isotopes (NASDAQ:ASPI) are both small-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, earnings and profitability.

Do institutionals and insiders believe in CC or ASPI?

76.3% of Chemours shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 0.5% of Chemours shares are owned by company insiders. Comparatively, 21.4% of ASP Isotopes shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Is CC or ASPI more profitable?

Chemours has a net margin of 1.51% compared to ASP Isotopes' net margin of -807.39%. Chemours' return on equity of 26.54% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	1.51%	26.54%	2.41%
ASP Isotopes	-807.39%	-123.83%	-51.58%

Does the MarketBeat Community believe in CC or ASPI?

Chemours received 631 more outperform votes than ASP Isotopes when rated by MarketBeat users. However, 100.00% of users gave ASP Isotopes an outperform vote while only 60.51% of users gave Chemours an outperform vote.

Company	Underperform	Outperform
Chemours	Outperform Votes 639 60.51%	Underperform Votes 417 39.49%
ASP Isotopes	Outperform Votes 8 100.00%	Underperform Votes No Votes

Which has more volatility & risk, CC or ASPI?

Chemours has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.4, meaning that its stock price is 240% more volatile than the S&P 500.

Do analysts prefer CC or ASPI?

Chemours currently has a consensus target price of $17.56, suggesting a potential upside of 66.17%. ASP Isotopes has a consensus target price of $6.67, suggesting a potential downside of 14.09%. Given Chemours' higher probable upside, research analysts clearly believe Chemours is more favorable than ASP Isotopes.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	0 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.56
ASP Isotopes	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has preferable earnings & valuation, CC or ASPI?

ASP Isotopes has lower revenue, but higher earnings than Chemours. ASP Isotopes is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.79B	0.27	-$238M	$0.20	52.83
ASP Isotopes	$4.14M	140.55	-$16.29M	-$0.61	-12.72

Does the media favor CC or ASPI?

In the previous week, Chemours and Chemours both had 15 articles in the media. Chemours' average media sentiment score of 0.66 beat ASP Isotopes' score of 0.22 indicating that Chemours is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	7 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
ASP Isotopes	2 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Chemours beats ASP Isotopes on 11 of the 17 factors compared between the two stocks.